Mark J. Gergen

Insider Reports History

Entity
Individual
Location
C/O Mirati Therapeutics Inc., 9393 Town Centre Drive, Ste 200, San Diego, CA
Signature
/s/ Harry J.Leonhardt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Gergen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Poseida Therapeutics, Inc. Executive Chairman, Director Common Stock 651K $2.69M $4.13 Mar 1, 2024 Direct
Poseida Therapeutics, Inc. Executive Chairman, Director Stock Option (Right to buy) 173K Jan 2, 2024 Direct

Insider Reports Filed by Mark J. Gergen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PSTX Poseida Therapeutics, Inc. Mar 1, 2024 1 -$141K 4 Mar 4, 2024 Executive Chairman, Director
PSTX Poseida Therapeutics, Inc. Feb 1, 2024 1 -$161K 4 Feb 2, 2024 Executive Chairman, Director
PSTX Poseida Therapeutics, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Executive Chairman, Director
PSTX Poseida Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 2, 2023 President and CEO, Director
PSTX Poseida Therapeutics, Inc. Feb 1, 2023 1 -$223K 4 Feb 3, 2023 President and CEO, Director
PSTX Poseida Therapeutics, Inc. Feb 1, 2022 2 $0 4 Feb 1, 2022 President and CEO, Director